These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 14695837)
1. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth. McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837 [TBL] [Abstract][Full Text] [Related]
2. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575 [TBL] [Abstract][Full Text] [Related]
3. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Engman L; Kandra T; Gallegos A; Williams R; Powis G Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308 [TBL] [Abstract][Full Text] [Related]
4. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. Kunkel MW; Kirkpatrick DL; Johnson JI; Powis G Anticancer Drug Des; 1997 Dec; 12(8):659-70. PubMed ID: 9448705 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors. Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system. Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002 [TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302. Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187 [TBL] [Abstract][Full Text] [Related]
10. Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents. Kirkpatrick DL; Watson S; Kunkel M; Fletcher S; Ulhaq S; Powis G Anticancer Drug Des; 1999 Oct; 14(5):421-32. PubMed ID: 10766297 [TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin-derived mimic of glutathione peroxidase exhibiting enzymatic specificity and high catalytic efficiency. Dong ZY; Huang X; Mao SZ; Liang K; Liu JQ; Luo GM; Shen JC Chemistry; 2006 Apr; 12(13):3575-9. PubMed ID: 16491491 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors. Millet R; Urig S; Jacob J; Amtmann E; Moulinoux JP; Gromer S; Becker K; Davioud-Charvet E J Med Chem; 2005 Nov; 48(22):7024-39. PubMed ID: 16250662 [TBL] [Abstract][Full Text] [Related]
13. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862 [TBL] [Abstract][Full Text] [Related]
14. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system. Wipf P; Lynch SM; Birmingham A; Tamayo G; Jiménez A; Campos N; Powis G Org Biomol Chem; 2004 Jun; 2(11):1651-8. PubMed ID: 15162219 [TBL] [Abstract][Full Text] [Related]
15. Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase. Yan K; Lok CN; Bierla K; Che CM Chem Commun (Camb); 2010 Nov; 46(41):7691-3. PubMed ID: 20623063 [TBL] [Abstract][Full Text] [Related]
16. Aromatic derivatives and tellurium analogues of cyclic seleninate esters and spirodioxyselenuranes that act as glutathione peroxidase mimetics. Back TG; Kuzma D; Parvez M J Org Chem; 2005 Nov; 70(23):9230-6. PubMed ID: 16268595 [TBL] [Abstract][Full Text] [Related]
17. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G Anticancer Drugs; 2003 Feb; 14(2):153-61. PubMed ID: 12569302 [TBL] [Abstract][Full Text] [Related]
18. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452 [TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo. Wang X; Zhang J; Xu T Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807 [TBL] [Abstract][Full Text] [Related]
20. Novel Water-Soluble Diorganyl Tellurides with Thiol Peroxidase and Antioxidant Activity. Kanda T; Engman L; Cotgreave IA; Powis G J Org Chem; 1999 Oct; 64(22):8161-8169. PubMed ID: 11674732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]